Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
national blog main
new york blog main
4
×
biotech
boston blog main
deals
life sciences
san diego blog main
san francisco blog main
astellas pharma
boston top stories
cancer
clinical trials
national top stories
new york top stories
raleigh-durham blog main
san francisco top stories
seattle blog main
seattle top stories
vertex pharmaceuticals
10x genomics
advance medical
american society of clinical oncology (asco)
american well
anti-inflammatory drugs
arcturus therapeutics
atlas venture
audentes therapeutics
avidity biosciences
avrobio
becton dickinson
best doctors
bluebird bio
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
cancer diagnostics
cancer immunotherapy
carlos nueno
What
reach
4
×
cash
deal
drug
expand
acquisition
add
adding
advance
ago
ahead
aims
ambien
american
annual
asco
attendees
attention
based
biotech
biotechs
borders
bought
buys
camp’s
cancer
chicago
city
clinical
combinations
community’s
company
considering
data
days
decisions
diagnostic
diagnostics
diseases
dyne
Language
unset
Current search:
reach
×
photo
×
" new york blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
5 years ago
Teladoc Buys Advance Medical for $352M to Expand Telehealth Services
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More